Product Information
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1384 per EA under NDC 59762106101. Its NADAC has been published 657 times since Nov 28, 2013.
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET
Diphenoxylate Hydrochloride and Atropine SulfateStrength
.025; 2.5 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762106101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA012462On Market Since
8/7/2012
Pharmacological Classes
Price Statistics
The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 17.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1384 per EA |
|---|---|
| All-time high | $0.5030 (Mar 14, 2018) |
| All-time low | $0.1181 (Nov 28, 2013) |
| 52-week high | $0.1840 |
| 52-week low | $0.1384 |
| Median price | $0.2418 |
| Average price | $0.2688 |
| Largest weekly change | +174.9% (Jul 16, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.1384 per EA (NDC 59762106101), effective Jun 24, 2026.
How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has risen 17.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
Since Nov 28, 2013, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has ranged from a low of $0.1181 (Nov 28, 2013) to a high of $0.5030 (Mar 14, 2018), with a median of $0.2418 per EA.
Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, but none are currently priced below it.
Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET (NDC 59762106101) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification